Analyst: Eli Lilly’s growth worries Novo investors but may be a positive indicator for next week’s financial results

Eli Lilly shows up to have energy in sales of GLP-1 medicines, however expert Søren Løntoft Hansen from Sydbank likewise has actually elevated his assumptions for Danish Novo Nordisk based upon the United States numbers.

发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/analyst-eli-lillys-growth-worries-novo-investors-but-may-be-a-positive-indicator-for-next-weeks-financial-results/

(0)
上一篇 2 11 月, 2025 3:20 上午
下一篇 2 11 月, 2025 3:20 上午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。